StayCurrentMD · Proliferative Effects of Mesenchymal Stromal Cells on Neuroblastoma Cell Lines: Are They Tumor Promoting or Tumor Inhibiting?
Follow
Article1 min read·Published Feb 2024Older

Proliferative Effects of Mesenchymal Stromal Cells on Neuroblastoma Cell Lines: Are They Tumor Promoting or Tumor Inhibiting?

jpedsurg.org shows its articles on its own site.

Read the article on jpedsurg.org ↗

Article · Feb 2024 · 1 min read

In brief

In brief

This study investigates whether mesenchymal stromal cells promote or inhibit neuroblastoma growth by comparing the effects of placental-derived and bone marrow-derived MSCs on neuroblastoma cell proliferation in vitro. Understanding MSC-tumor interactions is critical for developing MSC-based cellular therapies in high-risk pediatric neuroblastoma.

Written by the GCMD Library team from the article.

Neuroblastoma is a common pediatric malignancy with poor survival for high-risk disease. Mesenchymal stromal cells (MSCs) have innate tumor-homing properties, enabling them to serve as a cellular delivery vehicle, but MSCs have demonstrated variable effects on tumor growth. We compared how placental MSCs (PMSCs) and bone marrow-derived MSCs (BM-MSCs) affect proliferation of neuroblastoma (NB) cells in vitro.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →